Indian generic drug makers like Lupin, Dr Reddy’s Laboratories, Sun Pharma eye Japanese market – The Economic Times
0
Indian generic drug makers are exploring all options to get a foot in the door to Japan’s lucrative but difficult-to-crack $111-billion drug industry.
The penetration of generic drugs in Japan, the world’s largest drug market after the US and Europe is a little more than 30 per cent compared with more 80 per cent in the US drug market. The Japanese government now wants to raise this share to 60 per cent by 2017 as it looks to make healthcare affordable.
According to analysts and experts, companies including Lupin, Dr Reddy’s Laboratories, Sun Pharma, Glenmark, Shasun Pharma, Sami Labs and Aurobindo Pharma are making efforts to increase their business with Japan.
Read more – The Economic Times